TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹367 Cr | ₹281 Cr | ₹688 Cr | ₹544 Cr | ₹744 Cr |
What is the latest Capital Work in Progress ratio of TORRENT PHARMACEUTICALS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹367 Cr |
| Mar2024 | ₹281 Cr |
| Mar2023 | ₹688 Cr |
| Mar2022 | ₹544 Cr |
| Mar2021 | ₹744 Cr |
How is Capital Work in Progress of TORRENT PHARMACEUTICALS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹367 Cr | 30.79 | |
| Mar2024 | ₹281 Cr | -59.20 | |
| Mar2023 | ₹688 Cr | 26.44 | |
| Mar2022 | ₹544 Cr | -26.83 | |
| Mar2021 | ₹744 Cr | - | |
Compare Capital Work in Progress of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹133,314.4 Cr | -3.7% | 4% | 18.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,037.0 Cr | -3% | -3.6% | -4.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,795.0 Cr | -3.1% | 0.1% | 11.4% | Stock Analytics | |
| CIPLA | ₹116,933.0 Cr | -1.3% | -4.6% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,350.2 Cr | -4.2% | -7% | -11.4% | Stock Analytics | |
| MANKIND PHARMA | ₹91,355.8 Cr | -4.3% | 1.5% | -21.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -3.7% |
4% |
18.8% |
| SENSEX | -1.7% |
-1.4% |
7% |
You may also like the below Video Courses